LNSR (LENSAR Inc) Total Debt to Capital

Public company logo of LENSAR, Inc (LNSR)

LENSAR, Inc. (LNSR) produces high-precision lasers for ophthalmology, combining the procurement of electronics with in-house final assembly. The market dynamics reflected in the price action show a total debt-to-equity ratio of 0.08, confirming financial stability. Demand for such services depends on client wealth; therefore, sales grow during economic upturns. High brand authority among surgeons solidifies its status as a technological leader.

LNSR: LENSAR Debt to Capital 07/04/2022 - 10/31/2026

Analytical breakdowns and data insights for company LENSAR Inc (LNSR)

- stock quotes and analyst forecast:
Stock Quotes LENSAR|LNSR - Analyst Forecast Prices
- business market valuation indicators:
Market Capitalization LENSAR|LNSR - Value Adjusted for Debt and Cash
- book capitalization indicators:
Book Value per Share LENSAR|LNSR - Total Stockholders' Equity|Market Value to Book Value Ratio lensar.com|LNSR - Aggregate Asset Value
- company total debt and liquidity indicators:
Total Debt to Capital LENSAR, Inc.|LNSR - Long-Term Debt to Capital|Short-Term Debt to Equity LENSAR, Inc.|LNSR - Company Aggregate Indebtedness|Debts to Book Capitalization LENSAR|LNSR - Long-Term Debt|Company Current Liabilities LENSAR|Quick Liquidity Indicator lensar.com
- earnings and valuation multiples information:
LNSR - Profit After Payment of Taxes
Summary company analytics:LENSAR, LNSR
Finished products of LENSAR, Inc.

The total debt-to-equity ratio determines a business's degree of financial autonomy through the relationship between borrowed funds and equity. By analyzing the company's leverage history, an investor assesses the risk of excessive credit burden. This metric measures the share of external financing within the asset structure. For LENSAR, Inc. (LNSR), this balance is critical amid raw material supply chain volatility. An optimal debt level allows the company to mitigate geopolitical risks and regulatory barriers.

Competitors of LENSAR, Inc.

Total Debt to Equity Ratio DXCM|PEN (Penumbra Inc) - Aggregate Debt to Capital|Total Debt to Capital NOVT|HAE (Haemonetics Company) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital INSP (Inspire Medical Systems)|procept-biorobotics.com (PRCT) - Debt to Capital|CNMD - Debt to Equity|All Debt to Shareholders' Equity Ratio PLSE (Pulse Biosciences Inc)|INMD: Total Debt to Capital|Picard Group (PMI) - Total Debt to Capital|Debt to Equity Surmodics, Inc.|Senseonics Corp - Aggregate Debt to Equity|Total Debt to Capital NPCE|TCMD - Debt to Capital|SANUWAVE Health, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Outset Medical Corp OM|ELMD: Total Debt to Equity Ratio|avitamedical.com - Aggregate Debt to Capital|PROF: Total Debt to Capital|BDMD - Total Debt to Capital Coefficient|EDAP (EDAP TMS SA) - Total Debt to Capital|Total Debt to Equity Ratio Bovie Medical (APYX)|Total Debt to Equity Ratio ICCM (IceCure Medical Ltd)|LUNG (pulmonx.com) - All Debt to Shareholders' Equity Ratio|Debt to Equity TELA Bio TELA|CTSO - Total Debt to Equity Ratio|Sensus Healthcare Corp - Total Debt to Capital|Debt to Capital Zynex Corp|ECOR: Total Debt to Capital|Debt to Equity Ratio RBOT|IINN (Inspira Technologies Oxy B.H.N. Ltd.) - Total Debt to Capital|SeaStar Medical Holding Corporation (ICU) - Total Debt to Capital Coefficient|Total Debt to Capital IRIX|Total Debt to Equity Ratio ibs.inc INBS|Total Debt to Capital XAIR (Beyond Air)|Total Debt to Capital profusa.com PFSA|SSKN - Debt to Equity|GCTK: Debt to Equity|NAOV (NanoVibronix) - Total Debt to Equity Ratio|Venus Concept Corporation - All Debt to Shareholders' Equity Ratio|NUWE (Nuwellis, Inc.) - Total Debt to Capital|Debt to Capital aethlonmedical.com AEMD|Debt to Equity Asensus Surgical, Inc. (ASXC)|Avinger Inc. (AVGR) - Debt to Capital Ratio|BioSig Technologies, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Cutera Inc CUTR|Know Labs, Inc. - Total Debt to Capital|Total Debt to Capital Coefficient inarimedical.com NARI|Nevro (NVRO) - Debt to Equity|Aggregate Debt to Equity RSLS (ReShape Lifesciences Inc.)|Debt to Equity Silk Road Medical Inc.